ANKFY1 (Ankyrin Repeat and FYVE Domain Containing 1) is a multifunctional protein implicated in various cellular processes, including endocytosis, signaling pathway regulation, and intracellular trafficking. Characterized by its ankyrin repeats and a distinct FYVE domain, ANKFY1 plays a pivotal role in mediating the recruitment and tethering of vesicles to specific cellular compartments, thereby facilitating the endosomal transport of cargo molecules. Its involvement in these processes is crucial for maintaining cellular homeostasis, modulating signal transduction pathways, and ensuring the precise delivery of membrane proteins and lipids. The protein's function in routing and sorting endosomal cargo underlines its importance in cellular logistics, making it a critical component in the regulation of membrane dynamics and the spatial organization of intracellular signaling components.
The inhibition of ANKFY1 presents a complex challenge, as it necessitates targeting a protein that is integral to the endocytic pathway and intracellular trafficking system. Inhibition strategies would likely focus on disrupting the protein's ability to bind to membrane lipids or interact with other molecular constituents of the endosomal sorting machinery. This could be achieved through the design of small molecules or peptides that specifically bind to the ankyrin repeats or the FYVE domain of ANKFY1, thereby preventing its interaction with phosphatidylinositol 3-phosphate (PI3P) enriched membranes or its recruitment of endosomal vesicles. Additionally, targeting the regulatory mechanisms that control ANKFY1 expression or post-translational modifications could provide another avenue for inhibition, potentially impacting its localization and function. Given ANKFY1's role in crucial cellular processes, its inhibition would have significant implications for the regulation of endocytosis and intracellular trafficking. However, such interventions would need to be carefully designed to avoid disrupting the essential cellular functions that depend on these processes, highlighting the complexity of targeting proteins with central roles in cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a steroidal metabolite of fungi and acts as a potent, irreversible inhibitor of phosphoinositide 3-kinases (PI3K), which can affect endosomal trafficking, wherein ANKFY1 is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a morpholine derivative that inhibits PI3K, leading to disruptions in endosomal dynamics and potentially impacting ANKFY1-associated pathways. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a small molecule that non-competitively inhibits the GTPase activity of dynamin, a key player in vesicular trafficking, which can indirectly affect ANKFY1 function. | ||||||
Dynamin Inhibitor II | 1119-97-7 | sc-203931 sc-203931A sc-203931B sc-203931C | 5 g 250 g 500 g 1 kg | $47.00 $84.00 $124.00 $198.00 | ||
Dynamin Inhibitor II (MiTMAB) is a dynamin inhibitor that impedes on the clathrin-mediated endocytosis and, by extension, which inhibits ANKFY1-related endosomal functions. | ||||||
Hydroxy-Dynasore | 1256493-34-1 | sc-364678 | 10 mg | $255.00 | ||
Hydroxy-Dynasore is another potent inhibitor of dynamin, thus altering endocytic processes that ANKFY1 may be involved with by influencing vesicle scission. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is a cationic amphiphilic drug that can block clathrin-mediated endocytosis, potentially modulating ANKFY1's role in endosomal trafficking. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 is a clathrin inhibitor that disrupts clathrin-mediated endocytosis, which could indirectly affect the function of ANKFY1 in vesicular transport. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an isoflavone that can inhibit tyrosine kinases and may modulate cellular trafficking pathways, indirectly influencing ANKFY1. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is a lactone antibiotic that disrupts the Golgi apparatus and could affect the protein sorting and trafficking processes, thereby influencing ANKFY1 activity. | ||||||
Ikarugamycin | 36531-78-9 | sc-202179 | 500 µg | $189.00 | 4 | |
Ikarugamycin is an antibiotic that disrupts clathrin-mediated endocytosis, which could have an impact on ANKFY1's function in endosomal sorting. | ||||||